ALCLS:EPA
Cellectis SA
€1.13
arrow_upward
+0.18%(+0.0020) 1D
Oct 9, 5:35:14 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALCLS...
Open
€1.12
High
€1.16
Low
€1.11
Mkt. cap
73.37M
Avg. vol.
510.05K
Volume
0.00
52-wk high
€4.84
52-wk low
€1.09
EPS
-€0.58
Shares outstanding
72.09M
No. of employees
227
Open
€1.12
High
€1.16
Low
€1.11
Mkt. cap
73.37M
Avg. vol.
510.05K
Volume
0.00
52-wk high
€4.84
52-wk low
€1.09
EPS
-€0.58
Shares outstanding
72.09M
No. of employees
227
News stories
From web sources and news partners
Stock Titan
·
1 hour ago
A humanoid robot for developers and schools is among four launches planned for Oct. 14.
StreetInsider
·
11 minutes ago
XRP News Today: Nasdaq Exposure Could Transform XRP as Remittix Targets Everyday Payment Adoption
Stock Titan
·
50 minutes ago
In fiscal 2026, customers bought 466 vehicle energy storage systems from Scage.
Barchart.com
·
3 hours ago
The S&P 500 Is Near Record Highs. So Why Does Your Portfolio Feel Like a Bear Market?
Profile
Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina. Wikipedia
About Cellectis SA